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Abstract
Background. Stroke is a common cause of mortality and disability. There are many risk factors for stroke among 
which leukoaraiosis (LA) is mentioned. Historically, LA was a radiological term, however, today it is classified as 
Cerebral Small Vessel Disease (CSVD) which clinical presentation depends on the affected brain area. Higher preva-
lence of LA is found not only in stroke patients, but also in patients with hypertension and other cerebrovascular risk 
factors. Therefore, the aim of the study was to evaluate the relationship between the present LA, selected laboratory 
tests, the carotid ultrasound markers and cognitive tests results in patients with stroke.
Material and methods. The study included 102 patients (W: 56, M: 46) at the age of 70.9 ± 11.5 hospitalized due 
to stroke in the Stroke Unit of the Department of Neurology. The clinical assessment included NIHSS score, MMSE 
testing, laboratory blood tests, carotid duplex USG and CT scan of the brain. Patients were dichotomized based on 
the presence of LA in the CT scan.
Results. LA was present in 25 (24.5%) patients. It was more frequently found in older patients (>72 years old; 
p < 0.001). In the LA group, higher levels of LDL cholesterol (p = 0.002), lower hemoglobin concentration  
(p = 0.03) and higher platelets count (p = 0.04) were observed. The carotid ultrasound showed higher intima-
media complexes in the LA group (p = 0.02). The functional test showed lower scores on the clock test in patients 
with LA (p = 0.04). The presence of LA was three times less likely to be present in patients administered with  
beta1-adrenolytics (p = 0.03).
Conclusions. The occurrence of leukoaraiosis in patients with acute stroke is associated with clustering of other 
vascular risk factors cognitive impairment, and may be related to ongoing cardiovascular therapy.
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Introduction
Every two seconds someone in the world suffers from 
a stroke, causing serious consequences and affect-
ing daily routines and quality of life [1]. Annually, 
6 million people worldwide die as a result of a stroke, 
which constitutes the third most common cause of 
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death following myocardial infarctions and tumors 
[2]. Furthermore, among people over 45 years old, 
stroke is the most common cause of disability. How-
ever, these are not the only consequences of stroke. 
Another complex problem related to strokes arises 
from cognitive dysfunction which, alongside neuro-
logical impairment, influences financial, social and 
emotional aspects of the patients [2, 3]. Many stud-
ies have confirmed that even a minor stroke affects 
everyday routine, executive, cognitive or neurologi-
cal functions, what may contribute to difficulty in 
returning to work and as a consequence reduce pa-
tients’ quality of life. [4]
Healthcare and treatment methods are becoming 
increasingly better, which prolongs life expectancy 
and significantly reduces patients’ mortality. How-
ever, there are increasing numbers of disabled stroke 
patients, who require long-term care, rehabilitation 
and more frequent hospitalizations. That and many 
other factors have resulted in a continuous increase 
in financial expenditure on the health care system [2, 
5]. Numerous studies have documented that stroke 
risk factors control and early treatment strategies in-
troduction are efficacious in primary and secondary 
prevention. Among the risk factor, the most impor-
tant are: poor hypertension control, dyslipidemia, 
ischemic heart disease, arrhythmia, atherosclerosis, 
the presence of leukoaraiosis and lack of physical 
activity [6, 7].
After many years, Leukoaraiosis (LA) has not 
only become a radiological term, but also a complex 
clinical syndrome, the symptoms and pathogenesis 
of which have not yet been fully described [8, 9]. 
LA is currently classified as Cerebral Small Vessel 
Disease (CSVD) which is based on a chronic isch-
emia resulting from changes occurring in the small 
arteries of the brain [10]. In Computed Tomog-
raphy (CT) examination, it occurs in the form of 
hypodense changes, with varying degrees of density 
reduction compared to the normal white matter. In 
magnetic resonance imaging (MRI) in T2-depen-
dent images and FLAIR (fluid-attenuated inversion 
recovery) sequences, it appears as hyperintensive 
changes in relation to the normal white matter. LA 
is mainly located bilaterally in the periventricular 
regions [11].
Compared to a healthy population, a higher prev-
alence of LA is found not only in stroke patients but 
is also in patients with hypertension and other cere-
brovascular risk factors [6, 7]. Many studies revealed 
that not only does leukoaraiosis escalate the risk of 
stroke but it also affects the severity and worsens the 
prognosis (Modified Rankin Scale; mRS) [12]. It 
was also shown that the presence of leukoaraiosis is 
associated with an increase in patients’ mortality due 
to cardiovascular factors [13]. 
As the pathogenesis of LA is yet to be elucidated, 
the aim of our study was to prospectively evaluate 
the relationship between the occurrence of LA, lipid 
parameters, carotid and vertebral arteries Doppler 
ultrasound results,  and the presence of the cogni-
tive disorders in patient with a newly diagnosed 
stroke.
Material and Methods
Study Population
The presented study is a retrospective analysis of 
the data of patients with stroke hospitalized in 
the Stroke Unit of the Neurology Department in 
Zabrze, Medical University of Silesia. All data was 
obtained from the medical history of patients. The 
research group comprised 102 patients, including 56 
women and 46 men. The average age in the study 
population was 70.9 ± 11.5 years (mean ± SD) . 
Patients with defective awareness or aphasia were 
disqualified from the research due to the deficit of 
cognitive functions and they have not been taken 
into account in the total number of respondents. 
Every single patient was submitted to physical ex-
amination, neurological examination with the Na-
tional Institutes of Health Stroke Scale (NIHSS) 
evaluation upon admission to the ward. In order 
to assess cognitive dysfunctions, the Mini-Mental 
State Examination (MMSE) test was performed, 
the results of which were adapted for the age and 
period spent in education, as well as, the clock draw-
ing test (CDT). All patients underwent computed 
tomography (CT) examination of the brain, total 
cholesterol, LDL, HDL, triglycerides, as well as, 
carotid duplex ultrasonography with an assessment 
of intima-media thickness in the common carotid 
artery (CIMT — carotid intima-media thickness). 
CIMT measurements were performed on the distal 
wall of each of the common carotid arteries. The 
average value from three measurements carried out 
on each side was taken into account. Based on CT 
results, patients were divided into two subgroups: 
patients with leukoaraiosis (GSL test group with 
leukoaraiosis, n = 25) and those, where leukoaraiosis 
was not detected (GC control group, n = 77). 
Ethics
All clinical and demographic data, as well as, out-
come information were obtained retrospectively 
from the patients’ medical records. At the time of 
hospitalization, patients consented to all diagnostic 
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and treatment procedures which were pursuant to 
the guidelines appropriate for stroke. All procedures 
were performed in accordance with the Declaration 
of Helsinki on the treatment of human subjects.
Statistical analysis
The results were presented as mean values with stan-
dard deviations unless otherwise specified (continu-
ous parameters) and with percentages and frequen-
cies (categorical variables). Statistical significance was 
considered as a p-value of less than 0.05. Compara-
tive group analysis was performed using c2 Pearson 
test with Yates’ continuity correction for dichoto-
mous parameters and Student’s t-test for continuous 
variables. A logistic regression model with multiple-
chance odds ratios was performed. All analyses were 
performed using the software package Statistica (ver-
sion 12.5, StatSoft Inc., Tulsa, OK, USA). 
Results
The analysis of quantity and the division  
of the studied population
The study group was composed of 102 patients with 
newly diagnosed ischemic stroke. All of them un-
derwent neuroimaging examination i.e. Computed 
Tomography (CT) or magnetic resonance (MR). As 
a result of scans, Leukoaraiosis (LA) was diagnosed 
in 24.5% of hospitalized patients (GSC). Other pa-
tients, without typical changes for LA, constituted 
a control group (GC), which was compared with 
a group of patients with LA (Fig. 1).
Comparative analysis of demographics 
and pharmacotherapy in the study group
Both GSL and GC were composed of more women 
than men. The sex does not have an impact on the 
occurrence of leukoaraiosis. The patients with LA 
were older than CG (p < 0.001).
In both groups, a high level of comorbidities clas-
sified as risk factors for stroke was found. The most 
common comorbidities were hypertension, dyslip-
idemia and obesity. There was no difference in the 
frequency of these diseases in both GSL and GC.
Smokers constituted lower rate in group of pa-
tients with LA (p = 0.015). Compared to non-smok-
ers, significantly lower age was observed, at which 
patients with addiction suffered from a stroke (66.4 
± 9.8 vs. 75.1 ± 11.6; p = 0.005).
There was a significantly lower heart rate in the 
LA group, although remaining within the reference 
values (68 ± 10 vs. 77 ± 13; p = 0.003). However, 
there were no differences in the blood pressure values 
between both groups. 
The analysis of the ongoing pharmacotherapy 
showed that differences in the administration of 
beta1-adrenolytics are present in patient with vs. 
without LA (p = 0.03). Their use is associated with 
a 3 times less frequent occurrence of LA. No correla-
tion was observed with other groups of medicines.
Details about the characteristics of both groups 
were presented in Tables I and II.
Comparative analysis of laboratory tests 
in both groups
It is worth mentioning a dissimilarity in blood pa-
rameters that was observed. In the GSL group, the 
hemoglobin value was lower than in GC (p = 0,03), 
as well as a higher amount of platelets (p = 0.04). No 
other differences in blood test were noticed.
Differences in lipid parameters were observed. LA 
patients presented a higher than the upper limit of the 
normal value of LDL cholesterol level (p = 0.04) and 
a slightly higher value of total cholesterol (p = 0.08), 
moving towards the significance of statistical value. 
Patients with stroke
(n = 102)
Neuroimaging
(CT scan)
25 patients with leukoaraiosis
(GSL)
77 patients without leukoaraiosis
(GC)
Figure 1. Study flow chart. GC — control group; GSL — study group with leukoaraiosis; CT — computed tomography
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Detailed results of laboratory tests of both groups 
are presented in Table III.
Comparative analysis of imaging research, 
neurological condition and cognitive functions 
in both groups
In GSC, higher average values of CIMT in carotid 
arteries were noted. The thickness of IMC in left 
common carotid artery was 1.1 ± 0.3 in GSL group 
and 0.95 ± 0.2 in GC group (p = 0.02) (Fig. 2).
The relation between leukoaraiosis presence and 
NIHSS scale score was not demonstrated (p = 0.50).
The results of neurological examinations of pa-
tients from both groups were compared, however, 
no significant differences were found in the results. 
The relationship between the presence of leuko-
araiosis and cognitive disorders was noted. Patients 
with GSC scored lower in a Clock-Drawing test 
than patients from the control group. Median score 
of Clock-Drawing test in a group of patients with LA 
was 1, meanwhile, other patients obtained 5 points 
(p = 0.04). However, no link between the occurrence 
of leukoaraiosis and the results of MMSE test was 
evident.
The detailed results are presented in Table IV.
Prediction of leukoaraiosis based  
on the interview and basic laboratory test 
results
The logistic regression analysis of selected variables 
was performed. Univariate analysis showed that sev-
eral clinical variables are related to the presence of 
LA i.e.: age, LDL-levels and the use of beta-adreno-
receptor antagonists. However, no relationship was 
evident dihydropyridine calcium channel blockers. 
The presence of leukoaraiosis can be predicted with 
a sensitivity of 83% and specificity of 70%. 
Table III. Laboratory results of the study groups
Variable GSL (n = 25) GC (n = 77)
MMSE adjusted for age and 
education [points] 22±7 24±6
HCT (%) 38.5±5.8 39.8±5.9
RBC [×1012/L] 4.4±0.4 4.4±0.5
HGB [g/dL]* 12.9±2.4 13.8±1.5
WBC [×109/L] 8.1±1.9 8.9±4
PLT [×109/L]* 279±101.2 238.3±72.4
HDL level [mmol/L] 1.3±0.3 1.2±0.4
LDL level* [mmol/L] 3.5±1.2 2.6±1.1
Total cholesterol [mmol/L] 5.2±1.3 4.6±1.4
Triglycerides [mmol/L] 1.6±0.9 1.6±0.9
Serum albumin [g/L] 40.5±3 40±4.4
Serum protein [g/L] 68.6±5.8 66.8±5.6
CRP [mg/L] 8±9.5 14.7±31
Creatinine [µmol/L] 99.7±64.9 89.7±36
Values presented as means ± standard deviation (SD) or percentage of subjects; MMSE — Mini Men-
tal State Examination Scale; HCT — hematocrit; RBC — red blood cell; HGB — hemoglobin;  
WBC — white blood cell; PLT — blood platelets; HDL — high-density lipoprotein; LDL — low-density 
lipoprotein; CRP — C-reactive protein; GC — Control group; GSL — Study group with leukoaraiosis;  
*p < 0.05 study group (GSL) vs. control group (GC)
Table I. Clinical characteristic of the study groups
Variable GSL (n = 25) CG (n = 77)
Age* (years) 77.9 ± 7.1 68.6 ± 11.8
Males 8 (32%) 38 (49.4%)
BMI > 30 [kg/m2] 7 (29.4%) 32 (41.3%)
Stroke in the past 6 (24%) 17 (22.1%)
Myocardial infarction  
in the past 3 (12%) 16 (20.8%)
Brain trauma in the past 1 (4%) 4 (5.2%)
Hypertension 22 (88%) 71 (92.2%)
IHD 8 (32%) 22 (28.6%)
Dyslipidemia 18 (72%) 45 (58.4%)
Depression 4 (16%) 8 (10.3%)
Diabetes Mellitus 7 (28%) 24 (31.1%)
Smoking* 4 (16.7%) 44 (56.7%)
HR*[bpm] 68 ± 10 77 ± 13
Systolic BP [mm Hg] 144 ± 24 136 ± 28
Diastolic BP [mm Hg] 77 ± 12 79 ± 18
Alcohol drinking 1 (4%) 13 (16.9%)
Data presented as means ± standard deviation (SD) or number (percent) of subjects; BMI — body 
mass index; BPM — beats per minute; GSL — study group with leukoaraiosis; CG — control group; 
IHD — ischemic heart disease; HR — heart Rate; BP — blood pressure; *p < 0.05 study group (GSL) 
vs. control group 
Table II. Comparison of the ongoing drug regimens between the 
studied groups
Drug class GSL (n = 25) GC (n = 77) p-value
Statins 24 (96) 68 (88) 0.27
DHP-CCB 7 (28) 30 (39) 0.33
Beta-blockers 7 (28) 41 (53.2) 0.03
Nitrates 3 (12) 5 (6.5) 0.38
Diuretics 11 (44) 31 (40.2) 0.74
ACEIs/ARBs 18 (72) 47 (61) 0.33
PPIs 10 (40) 35 (45.5) 0.64
NSAIDs 0 (0.0) 3 (3.9) 0.32
ASA 16 (64) 50 (64.9) 0.93
NOAC or VKA 4 (16) 18 (23.3) 0.44
DHP-CCB — dihydropyridine calcium channel blockers; ACEIs — angiotensin converting enzyme inhi-
bitors; ARBs — angiotensin receptor blockers; PPIs — proton pump inhibitors; NOAC — non-vitamin 
K antagonist oral anticoagulant; NSAIDs — non-steroidal anti-inflammatory drugs other than ASA; 
ASA — acetylsalicylic acid; VKA = vitamin K antagonists; GC — Control group; GSL — Study group 
with leukoaraiosis
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Discussion
Leukoaraiosis is a significant clinical problem. It very 
often occurs among people with a newly recognized 
stroke, moreover, it also occurs in the general popula-
tion. [7, 9, 14] Our study confirms the wide dissemi-
nation of lesions typical for LA in the population of 
patients after a stroke, what was noted in almost ev-
ery fourth patient (Fig. 1). Although the etiology of 
LA has not been clearly established, it is known that 
its occurrence intensifies under the influence of typi-
cal cardiovascular risk factors [6, 7]. It can, therefore, 
be assumed that with the improvement of human 
living standards and changes in dietary structure, we 
will observe an increase in the incidence of LA in the 
population [14].
Previous research revealed that the incidence of 
LA increases with age. The age range not only affects 
the frequency but also the severity of symptoms that 
are associated with LA. Our study confirmed these 
reports because we showed that the occurrence of 
LA gradually increases with age, with a similar pat-
tern in men and women. It is hard to unequivocally 
determine the age limit above which the risk of LA 
increases rapidly, as it seems that this risk increases 
gradually over the next decades of life. Most pub-
lications indicate age over 60 as a risk factor for LA 
[7, 14]. Our results remain more optimistic, showing 
that a significant increase in risk occurs in the eighth 
decade of life.
Previous studies have shown that the incidence 
of LA is significantly higher in women than in men, 
suggesting that female sex is a significant risk factor 
for this disorder. Although in our study we did not 
show a statistically significant influence of gender, 
Table V. Associations of selected variables with the presence of 
leukoaraiosis. Univariate logistic regression analysis
Variable OR (95% CI) p-value
Age 1.01 (1.04–1.16) 0.002
DHP-CCB use 0.61 (0.27–1.63) 0.32
Beta-blockers use 0.34 (0.13–0.91) 0.03
Serum-LDL concentrations 1.83 (1.21–2.78) 0.005
DHP-CCB — dihydropyridine calcium channel blockers; LDL — low density lipoprotein; OR — odds 
ratio; CI — confidence interval
Table IV. Neurological findings upon physical examination in 
study groups
Variable GSL (n = 25) GC (n = 77)
Muscle strength on Lovett’s scale 3.5 ± 0.9 3.8 ± 1.1
Abnormal tendon reflexes 3 (12) 16 (20.8)
Sensory disturbance 1 (4) 5 (6.4)
Ataxia* 8 (32) 13 (16.9)
Presence of neurological abnor-
malities upon PE 5 (20) 31 (40.2)
NIHSS score upon admission 5.6 ± 3.7 6.5 ± 4.2
CN-III, CN-IV, CN-VI palsies* 2 (8) 1 (1.3)
CN-V palsy 1 (4) 1 (1.3)
CN-VII palsy 4 (16) 7 (9.1)
CN-VIII palsy 4 (16) 7 (9.1)
CN-X palsy 4 (16) 14 (18)
CN-XII palsy 5 (20) 23 (30)
Values presented as means ± standard deviation (SD) or number (percent) of subjects. NIHSS — Na-
tional Institutes of Health Stroke Scale; CN — cranial nerve; PE — physical examination; GC — control 
group; GSL — study group with leukoaraiosis; *p < 0.05 study group (GSL) vs. control group (GC)
Figure 2. Comparison of the value of intima-media thickness (IMT) common left carotid artery (CCA-L) in both groups; p = 0.02
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it is worth noting that women dominate in GSL 
(Tab. I). Considering a similar profile of diseases and 
disorders associated with both sexes, it seems that 
a higher incidence of LA in women is associated with 
physiological differences (including brain morpholo-
gy, hormone levels) [7, 15]. There is also a hypothesis 
that it was the loss of the protective effect of estrogen 
after menopause that is of significant meaning [16].
The results of our study clearly indicate that the 
presence of leukoaraiosis correlates with the sever-
ity of other cardiovascular risk factors [6, 7]. One 
of them is the occurrence of higher LDL values in 
the serum of patients with LA, exceeding the accept-
able norms (Tab. III). This is an interesting observa-
tion because, despite the well-known atherogenic 
effect of LDL, it does not equal with the risk of LA 
development. Only a few studies have linked high 
levels of LDL with leukoaraiosis, showing not so 
much of an increase in its occurrence, as intensifying 
the symptoms and intensity of changes in patients 
with LA already present [7, 17]. In our studies, we 
presented a positive correlation between abnormally 
high LDL values and the occurrence of LA. The ma-
jority of previous reports linking lipid disorders with 
leukoaraiosis showed a significant effect of elevated 
triglycerides and the presence of metabolic syndrome 
on the frequency of changes in periventricular white 
matter brain structures [7, 14]. However, we have 
not confirmed this relationship.
Our analysis also showed that patients with LA 
differ from the control group regarding the values 
of traditional blood count parameters. In GSL, sig-
nificantly lower hemoglobin values than those in GC 
were found, although they did not meet the criteria 
adopted by WHO (Tab. III). It cannot be unequivo-
cally determined what effect these lower values of 
hemoglobin had on LA development. However, it is 
worth mentioning, that anaemia in older patients has 
proven to affect cognitive functions impairment, ex-
ecutive dysfunctions in particular, as well as reduced 
physical fitness and increased mortality [18]. Thus, 
it affects the severity of symptoms that may be the 
symptoms of leukoaraiosis [11]. After taking these 
relationships into account, it must be assumed that 
the value of hemoglobin may have an influence on 
the pathogenesis of LA, even if the decrease is small 
(in the lower limits of the proper value). Undoubt-
edly, this issue requires a thorough analysis and more 
research, however, it cannot be ruled out that it 
may play a role in explaining a higher percentage of 
women in GSL. We also observed in the study that 
LA was associated with a significantly higher number 
of platelets (Tab. III). This observation is difficult to 
explain, but it requires attention due to the fact that 
the earlier studies have shown a relationship between 
the platelet volume (MPV) and the risk of LA lesions 
[19]. Therefore, the influence of a higher number of 
thrombocytes on the pathogenesis of changes in the 
white matter is also likely.
The presence of leukoaraiosis correlates not only 
with deviations in laboratory tests’ results but also 
abnormalities in imaging examinations. One of them 
is significantly higher rate of CIMT in left common 
carotid artery (CCA) in patients with LA (Fig. 2). 
This observation is in line with previous research 
reports, which also associated improperly high IMT 
values with the risk of LA [20]. This information 
supports a more complex etiology of changes in the 
white matter than assumed so far. Currently, the 
theory is that their pathogenesis is based mainly on 
microvascular ischemia [11]. High IMC values in-
dicate that the macrovascular component also plays 
a role, and LA is associated with chronic cerebral he-
moperfusion. It is not without significance that only 
left-side changes in the IMT value are observed. It is 
probably related to the difference in hemodynamic 
stress resulting from the anatomical differences of 
carotid arteries’ places of the inlet. These stresses may 
be exacerbated by hypertension, which in our study 
concerned 88% of patients in GSL. It is also worth 
noting that LA had a higher severity on the left side, 
which indicates the interrelationship of these irregu-
larities [20, 21].
An important aspect of our study was the dem-
onstration of the protective effect of beta-blockers. 
As already mentioned, their use was associated with 
a threefold decrease in the incidence of LA (Tab. II). 
Previous reports have shown that the use of anti-
hypertensive drugs is associated with a smaller in-
tensity of changes in the white matter of the brain, 
but they did not show any advantage of any group of 
drugs [22]. It is worth noting that, considering the 
slower heart rate found in GSL, beta-blockers pro-
tective function is unlikely to result from their basic 
negative chronotropic activity (Tab. I). The observed 
phenomenon may result from the pleiotropic mecha-
nism, often attributed to this group of medications.
Numerous publications indicate that LA is mani-
fested by cognitive dysfunctions, slower thinking, 
emotional dullness and limitation of spontaneity 
[23, 24]. However, its unambiguous influence on 
cognitive functions of patients is difficult to demon-
strate. In our study, we used the clock drawing test 
and MMSE to assess patients in this field. The results 
we have obtained also remain ambiguous. We were 
able to demonstrate the impact of LA on a significant 
reduction in the results of the clock drawing test, but 
we did not obtain significant differences in MMSE 
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results (Tab. III). The group led by Genlong Zhong 
received slightly different results, that still left space 
for doubts. They showed that the incidence of LA 
correlates with worse results of MMSE, while the 
intensity of these changes does not affect the results 
[25]. Based on current knowledge, it can be assumed 
that LA affects cognitive functions, but the precise 
determination of its role requires further research.
Leukoaraiosis can also be subclinical, producing 
less severe symptoms, incorrectly identified as natural 
changes associated with ageing. It should be under-
scored that in this case it is a significant risk of stroke, 
as well as a cardiovascular disease and they are associ-
ated with higher mortality [1, 7, 13]. Therefore, early 
identification of patients with LA is important, in 
which the prediction model presented in our work 
may be helpful, based on information on age, LDL 
values and pharmacotherapy.
Limitations of the study
The study was single-center, non-randomized and 
carried out on a small group of patients, so our results 
may not be generalized. To confirm our conclusions, 
a large randomized clinical trial is needed. In order 
to confirm the usefulness of a multiple-sensitivity of 
LA prediction model, it would be necessary to carry 
out a study assessing the occurrence of LA in patients 
who fulfil the criteria for the risk of the presence of 
LA, before they experienced a stroke.
Conclusions
The presence of leukoaraiosis in patients with stroke 
is a common finding, and it is closely related to 
cognitive impairment. Both, the ongoing pharmaco-
therapy and the number of coexisting cardiovascular 
risk factors may alter its course.
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